About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

U.S. Transplantation Market

U.S. Transplantation Market Future-proof Strategies: Trends, Competitor Dynamics, and Opportunities 2025-2033

U.S. Transplantation Market by Product Type (Tissue Products, Immunosuppressive Drugs, Preservation Solutions), by Application (Organ Transplantation, Tissue Transplantation), by End-user (Hospitals, Transplantation Centers, Others), by Forecast 2026-2034

Apr 1 2025

Base Year: 2025

120 Pages

U.S. Transplantation Market Future-proof Strategies: Trends, Competitor Dynamics, and Opportunities 2025-2033

Key Insights

The U.S. Transplantation Market size was valued at USD 11.37 Billion in 2023 and is projected to reach USD 12.43 Billion by 2032, exhibiting a CAGR of 9.1 % during the forecast period. Transplantation is the medical process of moving an organ to another person to replace a critically damaged part of the body. The other features of transplantation are that the organ must be cross-matched for acceptance by the recipient’s immune system and the necessity of administering immunosuppressive drugs to prevent rejection. There are also many benefits to being a transplant recipient. It can save lives, especially where organ failures take place, like in the kidneys, heart, or liver. For instance, kidney transplants often enable patients to avoid dialysis, and the consequences of the procedure on their quality of life are significant. Heart and liver transplant recipients will thus have their lives prolonged as well as their general body condition improved. The ability to function daily is also restored in cases such as corneal transplants for the improvement of sight or bone marrow transplants for the treatment of cancer or blood diseases.

U.S. Transplantation Trends

Rising prevalence of chronic diseases
Increased investment in research and development of new transplantation techniques
Growing acceptance of organ donation

U.S. Transplantation Market Market Size and Forecast (2024-2030) — U.S. Transplantation Market Company Market Share

Driving Forces: What's Propelling the U.S. Transplantation Market

Technological advancements in transplantation procedures
Government initiatives to promote organ donation
Increasing demand for specialized transplantation services

Challenges and Restraints in U.S. Transplantation Market

Shortage of donor organs
High cost of transplantation procedures
Potential for complications and rejection

Emerging Trends in U.S. Transplantation

Development of artificial organs
Use of stem cells in transplantation
Personalized medicine for transplantation patients

Growth Catalysts in U.S. Transplantation Industry

Increasing awareness of transplantation options
Growing number of skilled surgeons and medical professionals
Government funding for transplantation research

Market Segmentation: U.S. Transplantation Analysis

Product Type:

Tissue Products
Immunosuppressive Drugs
Preservation Solutions

Application:

Organ Transplantation
Tissue Transplantation

End-user:

Hospitals
Transplantation Centers
Others

Leading Players in the U.S. Transplantation Market

Significant Developments in U.S. Transplantation Sector

January 2023 – Zimmer Biomet Holdings, Inc. underwent a definitive agreement to acquire Embody, Inc. This acquisition includes Embody's complete portfolio of collagen-based biointegrative solutions, including the TAPESTRY, a biointegrative implant for tendon healing, and TAPESTRY RC, one of the first arthroscopic implant systems for rotator cuff repair.
July 2021 – TransMedics Group, Inc. received 510(k) clearance from the regulatory body U.S. Food and Drug Administration for OCS Lung Solution for use in transplants using cold storage techniques.
December 2020 – Biocon launched Tacrolimus capsules in the U.S. It is a calcineurin inhibitor used in organ transplant patients and helps to reduce the body’s ability to reject a transplanted organ.
March 2023 - The United Network for Organ Sharing (UNOS) reported a record number of organ transplants performed in the United States in 2022, with over 44,000 procedures completed. This marks a 6% increase from the previous year.
February 2023 - Vericel Corporation announced positive results from a Phase 3 clinical trial evaluating its investigational cell therapy, MACI, for the treatment of cartilage defects in the knee. The therapy demonstrated significant improvement in pain and function compared to the control group.

Comprehensive Coverage U.S. Transplantation Market Report

This report provides comprehensive coverage of the U.S. transplantation market, including key insights, emerging trends, growth catalysts, and challenges and restraints. The report also provides an in-depth analysis of market segmentation, leading players, and significant developments in the sector.

Regional Insight

The U.S. transplantation market is primarily driven by the regions with the highest population density and the largest number of hospitals and transplantation centres. The top regions in terms of revenue share are:

Northeast
West
South

U.S. Transplantation Market Market Share by Region - Global Geographic Distribution — U.S. Transplantation Market Regional Market Share

DROCT

The distribution of revenue across the country (DROCT) analysis provides insights into the geographic distribution of the market and the regions with the highest growth potential.

Pricing Analysis

The pricing analysis provides insights into the average cost of transplantation procedures and the factors that influence pricing, such as the type of transplant, the location of the procedure, and the hospital's pricing policy.

Import And Export Analysis

The import and export analysis provides insights into the international trade of transplantation products and services, such as the volume and value of imports and exports, and the major trading partners.

Segmentation

The segmentation analysis provides insights into the different segments of the transplantation market, such as product type (Tissue Products, Immunosuppressive Drugs), application, and end-user, and their respective market sizes and growth potential.

Patent/Trademark Analysis

The patent/trademark analysis provides insights into the intellectual property landscape of the transplantation market, such as the number of patents and trademarks filed, the key players involved, and the geographical distribution of intellectual property rights.

U.S. Transplantation Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 9.1%% from 2020-2034
Segmentation	By Product Type Tissue Products Immunosuppressive Drugs Preservation Solutions By Application Organ Transplantation Tissue Transplantation By End-user Hospitals Transplantation Centers Others By Geography

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Strong Demand for these Procedures to Augment Market Growth
- - 3.3. Market Restrains
  - - 3.3.1. Growing Competition from Generic Immunosuppressants to Hinder Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Strategic Initiatives among Various Organizations to Augment These Procedures is a Positive Market Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. U.S. Transplantation Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product Type
  - 5.1.1. Tissue Products
  - 5.1.2. Immunosuppressive Drugs
  - 5.1.3. Preservation Solutions
- 5.2. Market Analysis, Insights and Forecast - by Application
  - 5.2.1. Organ Transplantation
  - 5.2.2. Tissue Transplantation
- 5.3. Market Analysis, Insights and Forecast - by End-user
  - 5.3.1. Hospitals
  - 5.3.2. Transplantation Centers
  - 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by Region
  - 5.4.1.
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Novartis AG (Switzerland)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Teva Pharmaceutical Industries Ltd. (Israel)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Arthrex Inc. (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 F. Hoffmann-La Roche Ltd (Switzerland)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 Zimmer Biomet (U.S.)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Astellas Pharma Inc. (Japan)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Veloxis Pharmaceuticals Inc. (Asahi Kasei Corporation) (U.S.)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 BioLife Solutions (U.S.)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 TransMedics (U.S.)
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)

List of Figures

Figure 1: U.S. Transplantation Market Revenue Breakdown (undefined, %) by Product 2025 & 2033
Figure 2: U.S. Transplantation Market Share (%) by Company 2025

List of Tables

Table 1: U.S. Transplantation Market Revenue undefined Forecast, by Product Type 2020 & 2033
Table 2: U.S. Transplantation Market Volume K Units Forecast, by Product Type 2020 & 2033
Table 3: U.S. Transplantation Market Revenue undefined Forecast, by Application 2020 & 2033
Table 4: U.S. Transplantation Market Volume K Units Forecast, by Application 2020 & 2033
Table 5: U.S. Transplantation Market Revenue undefined Forecast, by End-user 2020 & 2033
Table 6: U.S. Transplantation Market Volume K Units Forecast, by End-user 2020 & 2033
Table 7: U.S. Transplantation Market Revenue undefined Forecast, by Region 2020 & 2033
Table 8: U.S. Transplantation Market Volume K Units Forecast, by Region 2020 & 2033
Table 9: U.S. Transplantation Market Revenue undefined Forecast, by Product Type 2020 & 2033
Table 10: U.S. Transplantation Market Volume K Units Forecast, by Product Type 2020 & 2033
Table 11: U.S. Transplantation Market Revenue undefined Forecast, by Application 2020 & 2033
Table 12: U.S. Transplantation Market Volume K Units Forecast, by Application 2020 & 2033
Table 13: U.S. Transplantation Market Revenue undefined Forecast, by End-user 2020 & 2033
Table 14: U.S. Transplantation Market Volume K Units Forecast, by End-user 2020 & 2033
Table 15: U.S. Transplantation Market Revenue undefined Forecast, by Country 2020 & 2033
Table 16: U.S. Transplantation Market Volume K Units Forecast, by Country 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Transplantation Market?

The projected CAGR is approximately 9.1%%.

2. Which companies are prominent players in the U.S. Transplantation Market?

Key companies in the market include Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Arthrex, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Zimmer Biomet (U.S.), Astellas Pharma Inc. (Japan), Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation) (U.S.), BioLife Solutions (U.S.), TransMedics (U.S.).

3. What are the main segments of the U.S. Transplantation Market?

The market segments include Product Type, Application, End-user.

4. Can you provide details about the market size?

The market size is estimated to be USD XXX N/A as of 2022.

5. What are some drivers contributing to market growth?

Strong Demand for these Procedures to Augment Market Growth.

6. What are the notable trends driving market growth?

Strategic Initiatives among Various Organizations to Augment These Procedures is a Positive Market Trend.

7. Are there any restraints impacting market growth?

Growing Competition from Generic Immunosuppressants to Hinder Market Growth.

8. Can you provide examples of recent developments in the market?

January 2023 – Zimmer Biomet Holdings, Inc. underwent a definitive agreement to acquire Embody, Inc. This acquisition includes Embody's complete portfolio of collagen-based biointegrative solutions, including the TAPESTRY, a biointegrative implant for tendon healing, and TAPESTRY RC, one of the first arthroscopic implant systems for rotator cuff repair.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in N/A and volume, measured in K Units.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "U.S. Transplantation Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the U.S. Transplantation Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the U.S. Transplantation Market?

To stay informed about further developments, trends, and reports in the U.S. Transplantation Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

Transplantation Market 2025 to Grow at 9.8 CAGR with 11.37 USD billion Market Size: Analysis and Forecasts 2033

U.S. Hair Transplant Procedure Market Navigating Dynamics Comprehensive Analysis and Forecasts 2025-2033

Hair Transplant Market Is Set To Reach USD billion By 2033, Growing At A CAGR Of 21.2

Transplantation Charting Growth Trajectories: Analysis and Forecasts 2025-2033

Transplantation Preservation Solutions Is Set To Reach XXX million By 2033, Growing At A CAGR Of XX

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report